<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35088194</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>07</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1573-7403</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>25</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Apr</Month>
            </PubDate>
          </JournalIssue>
          <Title>Pituitary</Title>
          <ISOAbbreviation>Pituitary</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Lymphocytic panhypophysitis and anti-rabphilin-3A antibody with pulmonary sarcoidosis.</ArticleTitle>
        <Pagination>
          <StartPage>321</StartPage>
          <EndPage>327</EndPage>
          <MedlinePgn>321-327</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s11102-021-01200-0</ELocationID>
        <Abstract>
          <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To explore the clinical significance of anti-rabphillin-3A antibody for the differential diagnosis of lymphocytic panhypophysitis.</AbstractText>
          <AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">A 58-year-old Japanese man developed uveitis of unknown cause in 2017. In 2019, he became aware of polyuria. In August 2020, he noticed transient diplopia and was diagnosed with right abducens nerve palsy. At the same time, he complained of fatigue and loss of appetite. Head magnetic resonance imaging demonstrated enlargement of the pituitary stalk and pituitary gland, corresponding to hypophysitis. Hormone stimulation tests showed blunted responses with respect to all anterior pituitary hormones. Central diabetes insipidus was diagnosed on the basis of a hypertonic saline loading test. Taking these findings together, a diagnosis of panhypopituitarism was made. Computed tomography showed enlargement of hilar lymph nodes. Biopsies of the hilar lymph nodes revealed non-caseating epithelioid cell granulomas that were consistent with sarcoidosis. Biopsy of the anterior pituitary revealed mild lymphocyte infiltration in the absence of IgG4-positive cells, non-caseating granulomas, or neoplasia. Western blotting revealed the presence of anti-rabphilin-3A antibody, supporting a diagnosis of lymphocytic panhypophysitis. Because the patient had no visual impairment or severe uveitis, we continued physiological hormone replacement therapy and topical steroid therapy for the uveitis.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">To the best of our knowledge, this is the first case of anti-rabphilin 3A antibody positive lymphocytic panhypophysitis comorbid with sarcoidosis, diagnosed by both pituitary and hilar lymph node biopsy. The utility of anti-rabphilin-3A antibody for the differential diagnosis of hypophysitis like this case should be clarified with further case studies.</AbstractText>
          <CopyrightInformation>© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Takahashi</LastName>
            <ForeName>Yuka</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, N-15, W-7, Kita-ku, Sapporo, 060-8638, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kameda</LastName>
            <ForeName>Hiraku</ForeName>
            <Initials>H</Initials>
            <Identifier Source="ORCID">0000-0003-1870-6688</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, N-15, W-7, Kita-ku, Sapporo, 060-8638, Japan. hkameda@huhp.hokudai.ac.jp.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Miya</LastName>
            <ForeName>Aika</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, N-15, W-7, Kita-ku, Sapporo, 060-8638, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nomoto</LastName>
            <ForeName>Hiroshi</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, N-15, W-7, Kita-ku, Sapporo, 060-8638, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cho</LastName>
            <ForeName>Kyu Yong</ForeName>
            <Initials>KY</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, N-15, W-7, Kita-ku, Sapporo, 060-8638, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nakamura</LastName>
            <ForeName>Akinobu</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, N-15, W-7, Kita-ku, Sapporo, 060-8638, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nishimura</LastName>
            <ForeName>Hiroki</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Respiratory Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kimura</LastName>
            <ForeName>Hirokazu</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Respiratory Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Suzuki</LastName>
            <ForeName>Masaru</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Respiratory Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Konno</LastName>
            <ForeName>Satoshi</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Respiratory Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shimizu</LastName>
            <ForeName>Ai</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Surgical Pathology, Hokkaido University Hospital, Sapporo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Matsuno</LastName>
            <ForeName>Yoshihiro</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Surgical Pathology, Hokkaido University Hospital, Sapporo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Okamoto</LastName>
            <ForeName>Michinari</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurosurgery, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Motegi</LastName>
            <ForeName>Hiroaki</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurosurgery, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Iwata</LastName>
            <ForeName>Naoko</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology, Diabetes and Metabolism, Fujita Health University, Toyoake, Japan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology and Diabetes, Daido Hospital, Nagoya, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fujisawa</LastName>
            <ForeName>Haruki</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology, Diabetes and Metabolism, Fujita Health University, Toyoake, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Suzuki</LastName>
            <ForeName>Atsushi</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology, Diabetes and Metabolism, Fujita Health University, Toyoake, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sugimura</LastName>
            <ForeName>Yoshihisa</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology, Diabetes and Metabolism, Fujita Health University, Toyoake, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Miyoshi</LastName>
            <ForeName>Hideaki</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, N-15, W-7, Kita-ku, Sapporo, 060-8638, Japan.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Diabetes and Obesity, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Atsumi</LastName>
            <ForeName>Tatsuya</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, N-15, W-7, Kita-ku, Sapporo, 060-8638, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>01</Month>
          <Day>28</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Pituitary</MedlineTA>
        <NlmUniqueID>9814578</NlmUniqueID>
        <ISSNLinking>1386-341X</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000069281" MajorTopicYN="Y">Autoimmune Hypophysitis</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020790" MajorTopicYN="Y">Diabetes Insipidus, Neurogenic</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007018" MajorTopicYN="Y">Hypopituitarism</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010902" MajorTopicYN="N">Pituitary Gland</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012507" MajorTopicYN="Y">Sarcoidosis</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017565" MajorTopicYN="Y">Sarcoidosis, Pulmonary</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Anti-rabphilin-3a antibody</Keyword>
        <Keyword MajorTopicYN="N">Lymphocytic panhypophysitis</Keyword>
        <Keyword MajorTopicYN="N">Panhypopituitarism</Keyword>
        <Keyword MajorTopicYN="N">Sarcoidosis</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>8</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>28</Day>
          <Hour>5</Hour>
          <Minute>56</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35088194</ArticleId>
        <ArticleId IdType="doi">10.1007/s11102-021-01200-0</ArticleId>
        <ArticleId IdType="pii">10.1007/s11102-021-01200-0</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Caturegli P, Newschaffer C, Olivi A, Pomper MG, Burger PC, Rose NR (2005) Autoimmune hypophysitis. Endocr Rev 26:599–614</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/er.2004-0011</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lupi I, Zhang J, Gutenberg A, Landek-Salgado M, Tzou SC, Mori S, Caturegli P (2011) From pituitary expansion to empty sella: disease progression in a mouse model of autoimmune hypophysitis. Endocrinology 152:4190–4198</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/en.2011-1004</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tzou SC, Lupi I, Landek M, Gutenberg A, Tzou YM, Kimura H, Pinna G, Rose NR, Caturegli P (2008) Autoimmune hypophysitis of SJL mice: clinical insights from a new animal model. Endocrinology 149:3461–3469</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/en.2007-1692</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lupi I, Broman KW, Tzou SC, Gutenberg A, Martino E, Caturegli P (2008) Novel autoantigens in autoimmune hypophysitis. Clin Endocrinol (Oxf) 69:269–278</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2265.2008.03180.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takao T, Nanamiya W, Matsumoto R, Asaba K, Okabayashi T, Hashimoto K (2001) Antipituitary antibodies in patients with lymphocytic hypophysitis. Horm Res 55:288–292</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11805433</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leporati P, Landek-Salgado MA, Lupi I, Chiovato L, Caturegli P (2011) IgG4-related hypophysitis: a new addition to the hypophysitis spectrum. J Clin Endocrinol Metab 96:1971–1980</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/jc.2010-2970</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iwama S, Sugimura Y, Kiyota A, Kato T, Enomoto A, Suzuki H, Iwata N, Takeuchi S, Nakashima K, Takagi H, Izumida H, Ochiai H, Fujisawa H, Suga H, Arima H, Shimoyama Y, Takahashi M, Nishioka H, Ishikawa SE, Shimatsu A, Caturegli P, Oiso Y (2015) Rabphilin-3A as a targeted autoantigen in lymphocytic infundibulo-neurohypophysitis. J Clin Endocrinol Metab 100:E946-954</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/jc.2014-4209</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hayashi H, Yamada K, Kuroki T, Katayama M, Shigemori M, Kuramoto S, Nonaka K (1991) Lymphocytic hypophysitis and pulmonary sarcoidosis. Report of a case. Am J Clin Pathol 95:506–511</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ajcp/95.4.506</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Steup-Beekman G, Zweers E (1998) Lymphocytic hypophysitis in a 43-year-old woman. Neth J Med 53:76–79</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0300-2977(98)00055-2</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cohen Aubart F, Galanaud D, Haroche J, Psimaras D, Mathian A, Hié M, Le-Thi Huong Boutin D, Charlotte F, Maillart E, Maisonobe T, Amoura Z (2017) Neurosarcoidosis: diagnosis and therapeutic issues. Rev Med Int 38:393–401</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.revmed.2016.10.392</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Honegger J, Schlaffer S, Menzel C, Droste M, Werner S, Elbelt U, Strasburger C, Störmann S, Küppers A, Streetz-van der Werf C, Deutschbein T, Stieg M, Rotermund R, Milian M, Petersenn S (2015) Diagnosis of primary hypophysitis in Germany. J Clin Endocrinol Metab 100:3841–3849</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/jc.2015-2152</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pal R, Rai A, Vaiphei K, Gangadhar P, Gupta P, Mukherjee KK, Singh P, Ray N, Bhansali A, Dutta P (2020) Intracranial germinoma masquerading as secondary granulomatous hypophysitis: a case report and review of literature. Neuroendocrinology 110:422–429</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000501886</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morimoto T, Azuma A, Abe S, Usuki J, Kudoh S, Sugisaki K, Oritsu M, Nukiwa T (2008) Epidemiology of sarcoidosis in Japan. Eur Respir J 31:372–379</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/09031936.00075307</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Statement on sarcoidosis (1999) Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee. Am J Respir Crit Care Med 160:736–755</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1164/ajrccm.160.2.ats4-99</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nozaki K, Judson MA (2012) Neurosarcoidosis: clinical manifestations, diagnosis and treatment. Presse Med 41:e331-348</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.lpm.2011.12.017</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zajicek JP, Scolding NJ, Foster O, Rovaris M, Evanson J, Moseley IF, Scadding JW, Thompson EJ, Chamoun V, Miller DH, McDonald WI, Mitchell D (1999) Central nervous system sarcoidosis–diagnosis and management. QJM 92:103–117</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/qjmed/92.2.103</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baughman RP, Nagai S, Balter M, Costabel U, Drent M, du Bois R, Grutters JC, Judson MA, Lambiri I, Lower EE, Muller-Quernheim J, Prasse A, Rizzato G, Rottoli P, Spagnolo P, Teirstein A (2011) Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG task FORCE. Sarcoidosis Vasc Diffuse Lung Dis 28:56–64</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21796892</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anthony J, Esper GJ, Ioachimescu A (2016) Hypothalamic-pituitary sarcoidosis with vision loss and hypopituitarism: case series and literature review. Pituitary 19:19–29</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11102-015-0678-x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Christ-Crain M, Bichet DG, Fenske WK, Goldman MB, Rittig S, Verbalis JG, Verkman AS (2019) Diabetes insipidus. Nat Rev Dis Prim 5:54</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41572-019-0103-2</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
